Cancer Chemotherapy and Pharmacology · 2012 · 33 citations · 17 references
MedicineOncologyPharmacologyChemotherapyMedical OncologySurgical OncologyAdjuvant ChemotherapyAdjuvant TherapyMalignant NeoplasmsNeoadjuvant ChemotherapyNeoadjuvant TherapyToxicity ManagementCervical Cancer ChemotherapyComplete Response AssessmentNeoadjuvant Platinum-based TherapyNeoadjuvant Taxane-based TherapyPartial Response AssessmentPlatinum-based RegimensTaxane-based ChemotherapyTaxane-based Combinations
PURPOSE: There are no reports on the use of neoadjuvant chemotherapy (NAC) in non-squamous cell cervical carcinoma. We examined the effectiveness and safety of paclitaxel/carboplatin (TC) and docetaxel/carboplatin (DC). METHODS: Stage Ib2 to IIb disease was present in 23 patients scheduled for radical hysterectomy. We administered 1-3 courses of either the TC or the DC regimen. Anti-tumor effects were found superior by Response Evaluation Criteria in Solid Tumors. Safety was assessed with National Cancer Institute Common Terminology Criteria for Adverse Events. RESULTS: Median age was 50 years (range 32-63 years), with stage Ib2 in 6 cases (26.1%) and IIb in 17 cases (73.9%). Complete response was achieved in 5 cases (21.7%), partial response in 13 (56.5%), stable disease in 5 (21.7%); the response rate was 78.3%, and surgery completion rate was 78.3%. Leukopenia or neutropenia ≥grade 3 was seen in 12 (52.2%) and 21 (91.3%) cases, respectively, with grade 3 febrile neutropenia in 2 cases (8.7%) and no anemia or thrombocytopenia ≥grade 3. Median progression-free survival was 26 months (95% Cl, 13.5-38.5 months); median overall survival was 35 months (95% Cl, 20.9-49.1 months). CONCLUSION: NAC for non-squamous cell cervical carcinoma showed potent anti-tumor effects and manageable adverse events.
17
William A. Peters, P.Y. Liu, Rolland J. Barrett et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer
Fabio Landoni, Andrea Maneo, Alessandro Colombo et al. · The Lancet · 1997 · 1.7K citations